SELLAS Life Sciences (SLS) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 99.28% |
| Sep 30, 2025 | -44,220.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -448.85% |
| Sep 30, 2024 | 97.48% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 99.58% |
| Dec 31, 2023 | 85.23% |
| Sep 30, 2023 | -3,869.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -23,802.00% |
| Dec 31, 2022 | 19.81% |
| Sep 30, 2022 | 99.62% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 99.64% |
| Dec 31, 2021 | 39.51% |
| Sep 30, 2021 | -220.73% |
| Jun 30, 2021 | 96.97% |
| Mar 31, 2021 | -27,900.00% |
| Dec 31, 2020 | -35,202.00% |
| Sep 30, 2020 | -7,030.43% |
| Jun 30, 2020 | -3,200.00% |
| Mar 31, 2020 | 96.12% |
| Dec 31, 2019 | 98.13% |
| Sep 30, 2019 | -15.00% |
| Jun 30, 2019 | 98.84% |
| Mar 31, 2019 | 70.09% |
| Dec 31, 2018 | 58.14% |
| Sep 30, 2018 | 99.22% |
| Jun 30, 2018 | 36.75% |
| Mar 31, 2018 | 52.42% |
| Dec 31, 2017 | -110.85% |
| Sep 30, 2017 | 47.38% |
| Jun 30, 2017 | 30.59% |
| Mar 31, 2017 | -4,413.72% |
| Dec 31, 2016 | -332.86% |
| Sep 30, 2016 | 29.37% |
| Jun 30, 2016 | 56.73% |
| Mar 31, 2016 | 99.24% |
| Dec 31, 2015 | 94.09% |
| Sep 30, 2015 | -40.82% |
| Jun 30, 2015 | -15.62% |
| Mar 31, 2015 | -0.83% |
| Dec 31, 2014 | 50.51% |
| Sep 30, 2014 | 52.04% |
| Jun 30, 2014 | -87.21% |
| Mar 31, 2014 | -199.91% |
| Dec 31, 2013 | -45.66% |
| Sep 30, 2013 | 0.00% |
| Jun 30, 2013 | -8.79% |
| Mar 31, 2013 | -100.91% |
| Dec 31, 2012 | 31.35% |
| Sep 30, 2012 | -227.51% |
| Jun 30, 2012 | -7.22% |
| Mar 31, 2012 | 21.72% |
| Dec 31, 2011 | -593.47% |
| Sep 30, 2011 | -453.35% |
| Jun 30, 2011 | -252.11% |